A major problem in assessing the role of calpains in apoptosis inducti
on concerns the fact that calpain inhibitors can also impair the activ
ity of the proteasome, also reported to be involved in apoptosis. Here
in we showed that apoptosis induced by calphostin C in U937 human prom
onocytic leukemia cells was associated, at its onset, with enhanced pr
otein (poly)ubiquitination. This observation prompted us to study whet
her protein degradation through the ubiquitin/proteasome pathway was i
nvolved in apoptosis induction. We found that N acetyl-Leu-Leu-norleuc
inal (50 mu M), a proteasome as well as a calpain inhibitor, was able
to reduce calphostin C-induced apoptosis by approximately 60%, whereas
lactacystin (10 mu M), a specific proteasome inhibitor, was ineffecti
ve. These results suggest that calphostin C-induced apoptosis is partl
y calpain-mediated, but does not require protein degradation through t
he ubiquitin/proteasome pathway. BIOCHEM PHARMACOL 56;11:1489-1492, 19
98. (C) 1998 Elsevier Science Inc.